Faster diagnosis for deadly blood clotting disorder on the horizon
NCT ID NCT05046717
Summary
This study aims to validate a new, faster automated blood test for diagnosing and monitoring a rare and serious blood disorder called acquired Thrombotic Thrombocytopenic Purpura (aTTP). It will involve up to 500 patients in Spain and Portugal, comparing the new test against older, slower methods. The goal is to provide quicker and more reliable results to help doctors start the right treatment sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Hospitalar e Universitario de Coimbra
Coimbra, Coimbra District, 3004-561, Portugal
-
Complejo Hospitalario Universitario A Coruña
A Coruña, A Coruña, 15006, Spain
-
Hospital Clinic de Barcelona
Barcelona, Spain
-
Hospital Clínico San Carlos
Madrid, Spain
-
Hospital Gregorio Marañon
Madrid, Spain
-
Hospital La Fe de Valencia
Valencia, Spain
Conditions
Explore the condition pages connected to this study.